日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combining sorafenib with spermine and sphingosine synergistically enhances anticancer efficacy by modulating metabolic pathways and gut microbiome in hepatocellular carcinoma

索拉非尼与亚精胺和鞘氨醇联合使用,可通过调节代谢途径和肠道微生物群,协同增强肝细胞癌的抗癌疗效。

Jang, Hay-Ran; Kim, Hyun-Jin; Kim, Bo-Young; Jeong, Jae-Hoon; Kim, Jeon-Kyung; Won, Jin Ah; Yoo, Hye Hyun; Lee, Yong Gu; Yim, Hyungshin

Correction: PLK1/vimentin signaling facilitates immune escape by recruiting Smad2/3 to PD-L1 promoter in metastatic lung adenocarcinoma

更正:PLK1/波形蛋白信号通路通过在转移性肺腺癌中募集Smad2/3至PD-L1启动子来促进免疫逃逸。

Jang, Hay-Ran; Shin, Sol-Bi; Kim, Chang-Hyeon; Won, Jae-Yeon; Xu, Rong; Kim, Da-Eun; Yim, Hyungshin

Combination of Inhibitors of USP7 and PLK1 has a Strong Synergism against Paclitaxel Resistance.

USP7 和 PLK1 抑制剂的组合对紫杉醇耐药性具有很强的协同作用

Shin Sol-Bi, Kim Chang-Hyeon, Jang Hay-Ran, Yim Hyungshin